Clover Biopharmaceuticals
Ejecutivos
Ver el organigrama con sus 24 ejecutivos principales
Biografías más buscadas en Clover Biopharmaceuticals
- Joshua Liang, Chief Executive Officer
- Xiang Liao, Independent Non-executive Director
- Donna Ambrosino, Director
Crear su alerta
para seguir los movimientos de los ejecutivos en Clover Biopharmaceuticals.
Farmacia
Clover Biopharmaceuticals tiene 1.863 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacia
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado el 23 de marzo de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado el 19 de marzo de 2024).
- Frontier Medicines acaba de anunciar una recaudación de fondos de 80 millones de dólares. (publicado el 27 de febrero de 2024).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Clover Biopharmaceuticals
- Clover’s COVID-19 Vaccine Candidate Demonstrates Strong Cross-Neutralization Against Omicron as a Homologous Booster | Clover Biopharmaceuticals, Ltd.
- Clover Doses First Participants in Phase 3 Trial Evaluating SCB-2019 as a Heterologous COVID-19 Booster Following Prior Vaccination with Inactivated, mRNA or Viral Vector Vaccines | Clover Biopharmaceuticals, Ltd.
- Clover Provides Update on 2022 Corporate Milestones | Clover Biopharmaceuticals, Ltd.
- Clover Doses First Participants in Phase 1 Trial with SCB-2020S, a Potentially Broadly Protective Chimeric COVID-19 Vaccine Candidate | Clover Biopharmaceuticals, Ltd.
- Clover’s Bivalent COVID-19 Vaccine Candidate Demonstrates Broad Neutralization Against Omicron and Other Variants of Concern | Clover Biopharmaceuticals, Ltd.
- Clover Appoints LiongHo Chua as President of Greater China | Clover Biopharmaceuticals, Ltd.
- Clover’s COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial - Clover Biopharmaceuticals
- Clover and CEPI Expand Partnership for COVID-19 Vaccine Candidate to Include Evaluation as a Booster - Clover Biopharmaceuticals
- Clover Biopharmaceuticals Announces Offer Price and Allotment Results of the Global Offering - Clover Biopharmaceuticals
- Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate - Clover Biopharmaceuticals
- View more press releases Close
Redes sociales sobre Clover Biopharmaceuticals
- Clover Biopharmaceuticals en Wikipedia, Google News y Yahoo Finance
- Clover Biopharmaceuticals en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Joshua Liang 
Llame a Clover Biopharmaceuticals al +86 288...
